SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
Rhea-AI Summary
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, announced its participation in the Goldman Sachs 46th Global Healthcare Conference in Miami Beach. The company's management will conduct a fireside chat on June 10, 2025, at 8:20 AM PT/11:20 AM ET. Investors can access the live webcast through registration and the company's website. The webcast recording will be available for replay on SI-BONE's investor relations page for at least 90 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, SIBN gained 2.65%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Goldman Sachs 46th Global Healthcare Conference in Miami Beach, FL. Management will be hosting a fireside chat on Tuesday, June 10, 2025, at 8:20 a.m. Pacific Time/11:20 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: Glodman Sachs 46th Healthcare Conference. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System®, SI-BONE has supported over 4,500 physicians in performing a total of over 120,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies with over 160 peer reviewed publications including two randomized controlled trials. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE, Sacropelvic Solutions, iFuse Implant System®, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal, investors@si-bone.com
FAQ
When is SI-BONE (SIBN) presenting at the Goldman Sachs Healthcare Conference 2025?
How can investors access SI-BONE's (SIBN) presentation at the Goldman Sachs Conference?
How long will SI-BONE's (SIBN) Goldman Sachs Conference webcast be available for replay?
What type of presentation will SI-BONE (SIBN) give at the Goldman Sachs Healthcare Conference?
